Key result
The zebrafish zShal3 potassium channel subunit exhibits similar functional and pharmacological characteristics to the mammalian Kv4.3 subunit, including regulation by NCS-1 and blockade by 4-AP and flecainide.
The zebrafish zShal3 K+ channel subunit shares highly conserved biophysical and pharmacological properties with its mammalian ortholog Kv4.3, supporting the use of zebrafish as a model for studying cardiac and neuronal electrophysiology.
Answers are grounded in this paper and cite their sources.
Supports zebrafish as a model for Kv4.3 electrophysiology; leaves open translation to human arrhythmias or therapies.
BACKGROUND: K+ channels are diverse; both in terms of their function and their molecular composition. Shal subunits were first described in Drosophila. There are three mammalian orthologs, which are members of the Kv4 subfamily. They are involved in neuronal firing patterns as well as control of the cardiac action potential duration. RESULTS: Here, we report the biophysical and pharmacological characterization of zShal3, which is the ortholog of the mammalian Kv4.3 subunit, which in mammals is involved in action potential repolarization and gives rise to neuronal A-type K+ currents involved in somatodendretic signal integration. CONCLUSION: We demonstrate that zShal has similar functional and pharmacological characteristics compared to Kv4.3 and it is similarly regulated by pharmacological agents and by the Kv4 accessory subunit, NCS-1.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2008) studied this question. zShal3 characterization was evaluated on Biophysical and pharmacological properties of zShal3. The zebrafish zShal3 potassium channel subunit exhibits similar functional and pharmacological characteristics to the mammalian Kv4.3 subunit, including regulation by NCS-1 and blockade by 4-AP and flecainide.
Synapse has enriched 10 related papers. Consider them for comparative context: